State of the Science Summit - Hematologic Malignancies: Chaired by Rebecca Klisovic, MD

Commentary
Article

State of the Science Summit - Hematologic Malignancies: Chaired by Rebecca Klisovic, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Rebecca Klisovic, MD

Speakers

  • Molly Gallogly, MD, PhD | University Hospitals Seidman Cancer Center
  • Leland Metheny, MD | University Hospitals Seidman Cancer Center
  • Benjamin Tomlinson, MD | University Hospitals Seidman Cancer Center
  • Changchun Deng, MD, PhD | University Hospitals Seidman Cancer Center
  • James Ignatz-Hoover, MD | University Hospitals Seidman Cancer Center

Topics

  • Panel Discussion & Case Presentation: Which JAK Inhibitor for MF?
  • Updates in MDS and AML
  • Treatment Crossroads: Sequencing BTK Inhibitors in CLL
  • A New Era: Bispecifics for Hematologic Malignancies
  • Exciting Studies to Look for in 2024 in Hematologic Malignancies

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Ibrahim Aldoss, MD
Kateryna Fedorov, MD, assistant professor, hematology-oncology, Vanderbilt University Medical Center
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Annie Im, MD, FASCO
Elias Jabbour, MD
Marc J. Braunstein, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine